A carregar...

Phase 2 Clinical Trial of Intrathecal Topotecan in Children with Refractory Leptomeningeal Leukemia: A Children’s Oncology Group Trial (P9962)

PURPOSE: We performed a phase 2 study in children with recurrent or refractory leptomeningeal leukemia to determine the objective response rate after treatment with intrathecal topotecan. PATIENTS AND METHODS: Patients received age-adjusted intrathecal topotecan (0.4 mg/dose for patients > 3 year...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Potter, Samara L. Poplack, Berg, Stacey, Ingle, Ashish Mark, Krailo, Mark, Adamson, Peter C., Blaney, Susan M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3242923/
https://ncbi.nlm.nih.gov/pubmed/21910214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.23317
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!